Zika Virus Vaccine is charted for the prevention of symptoms and complications of Zika virus infections in humans. This virus is basically transmitted through Aedes mosquito bite which can also transmit chikungunya, dengue, and yellow fever. Other modes of transmission of this virus is through sex and from an infected mother to the fetus.
MARKET DYNAMICS
The Zika Virus Vaccines market is anticipated to grow in the forecast period owing to driving factors such as increasing incidence of Zika-infected individuals, increasing degree of preparedness in case of future outbreaks of Zika infections, growing awareness, and increasing human trials. Nevertheless, high cost required for R&D may restrict the growth of the market during the forecast period.
MARKET SCOPE
The "Global Zika Virus Vaccines Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Zika Virus Vaccines market with detailed market segmentation by Type, Application, End User and geography. The global Zika Virus Vaccines market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Zika Virus Vaccines market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global Zika Virus Vaccines market is segmented on the basis of Type, Application and End User. Based on Type the market is segmented into DNA- based vaccines, Inactivated Vaccines, Live-attenuated Vaccines, mRNA Vaccines and Genetically Engineered Vaccines. Based on Application the market is segmented into Therapeutic Vaccines and Preventive Vaccines. Based on End User the market is segmented into Hospitals and Clinics.
(image)
REGIONAL FRAMEWORKThe report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Zika Virus Vaccines market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Zika Virus Vaccines market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Zika Virus Vaccines market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Zika Virus Vaccines market in these regions.
(image)
MARKET PLAYERSThe reports cover key developments in the Zika Virus Vaccines Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Zika Virus Vaccines Market are anticipated to lucrative growth opportunities in the future with the rising demand for Zika Virus Vaccines in the global market. Below mentioned is the list of few companies engaged in the Zika Virus Vaccines market.
The report also includes the profiles of key Zika Virus Vaccines market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
-Bharat Biotech International Ltd.
-GeneOne Life Science Inc.
-GlaxoSmithKline Plc.
-Hawaii Biotech Inc.
-Immunovaccine Inc.
-Inovio Pharmaceuticals, Inc.
-NewLink Genetics Co.
-Sanofi S.A.
-Takeda Pharmaceutical Co. Ltd.
-Cerus Corporation
(image)